Is It Legal to Buy CJC-1295 (No DAC) for Research in the US?

The short version: CJC-1295 (No DAC) regulatory status at a glance

In the United States, purchasing CJC-1295 (No DAC) is legal when intended exclusively for non-clinical laboratory research, in vitro assays, and preclinical animal studies. The compound is not classified as a scheduled controlled substance under the Controlled Substances Act (CSA), meaning federal law does not restrict its possession or procurement by qualified research personnel.

However, CJC-1295 (No DAC) is not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary medical use. Selling or buying this compound for personal administration, therapeutic protocol execution, or dietary supplementation violates federal drug safety laws under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Legitimate procurement requires purchasing through established research chemical vendors who enforce strict Research Use Only (RUO) compliance terms. Every order placed with PX1 Research requires the buyer to attest that the material will be handled within a qualified laboratory setting in accordance with federal and state regulations.

To ensure compliance and experimental validity, institutional buyers should verify that every reagent lot is accompanied by independent analytical documentation. You can review complete analytical documentation for our catalog via the CJC-1295 (No DAC) product page.

Is CJC-1295 (No DAC) legal to buy in the United States?

From a statutory perspective, CJC-1295 (No DAC)—frequently designated in scientific literature as Modified GRF 1-29—occupies a clear legal position under federal jurisdiction. It is an unscheduled chemical compound. It does not appear on any schedules established by the Drug Enforcement Administration (DEA), nor is it subject to DEA registration, quota allocations, or special record-keeping protocols required for controlled substances.

Because it is an unscheduled peptide, research laboratories, academic institutions, biotech firms, and independent investigators can legally purchase, transport, and store CJC-1295 (No DAC) across all 50 U.S. states without a federal DEA license or state medical license, provided the intended application remains non-clinical.

The legal foundation for purchasing research peptides relies on the intended use exemption. Under federal statutes, chemicals that are not scheduled drugs and are not sold for consumption or clinical application can be manufactured, distributed, and acquired freely for laboratory experimentation.

FDA regulatory classification and the Research Use Only (RUO) framework

Understanding the legal status of CJC-1295 (No DAC) requires distinguishing between clinical therapeutics and laboratory reagents. The FDA regulates products intended to diagnose, cure, mitigate, treat, or prevent disease in humans or animals. Because CJC-1295 (No DAC) has not undergone FDA pre-market review or safety testing for human application, it cannot be legally marketed or sold as a medicine, drug, or dietary supplement.

Under the RUO framework, manufacturers and suppliers are permitted to synthesize and distribute synthetic peptides provided they are labeled explicitly for laboratory research use only. This exemption allows scientific exploration into peptide kinetics, cellular receptor pathways, and biological mechanisms without requiring full investigational new drug (IND) approvals that govern human trials.

Suppliers who violate this framework by offering dosage guidelines, administration protocols, or marketing peptides for physical enhancement operate outside federal law. PX1 Research adheres strictly to RUO guidelines, ensuring that our reagents remain dedicated solely to advancing preclinical science.

What research buyers attest to when purchasing CJC-1295 (No DAC)

When purchasing CJC-1295 (No DAC) or any item from our catalog, buyers enter into a binding research agreement at checkout. This attestation serves as a vital safeguard for both the supplier and the research institution, reinforcing the legal boundaries established by domestic regulatory bodies.

By completing a transaction, the purchasing agent or researcher attests to the following core criteria:

1. Laboratory Qualification: The purchaser represents an institutional, academic, corporate, or qualified independent laboratory equipped with appropriate scientific apparatus and safety containment.

2. Non-Clinical Intent: The material will be used exclusively for in vitro research, cell culture studies, or preclinical animal models. It will not be administered to humans under any circumstances.

3. Handling and Biosafety Compliance: The buyer possesses the necessary training and safety infrastructure to handle lyophilized synthetic peptides, handle reconstitutions safely, and dispose of biochemical waste according to local environmental rules.

4. Prohibition of Resale for Consumption: The buyer will not repackage, re-label, or distribute the compound as a commercial health product, drug, or cosmetic.

This legal barrier protects the integrity of the research supply chain and guarantees that high-purity peptides are distributed solely to scientific investigators.

Research applications: How GHRH analogs like CJC-1295 (No DAC) are evaluated

In preclinical research models, CJC-1295 (No DAC) is categorized as a growth hormone-releasing hormone (GHRH) analog. Specifically, it is a 29-amino acid synthetic peptide representing a modified sequence of endogenous GHRH (tetrasubstituted GRF 1-29).

Preclinical studies suggest that CJC-1295 (No DAC) acts as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. By binding to the GHRH receptor on pituitary somatotropes, it stimulates pulsatile growth hormone secretion, allowing researchers to study endocrine signaling pathways, cellular regeneration, collagen deposition, and protein synthesis kinetics in cell lines and animal models.

Unlike native GHRH, which exhibits a rapid plasma half-life of roughly 7 to 12 minutes due to enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV), CJC-1295 (No DAC) incorporates specific amino acid substitutions (D-Ala, Gln, Ala, and Leu at positions 2, 8, 15, and 27) that enhance resistance to enzymatic degradation while maintaining binding affinity. Detailed molecular profiles are available in our CJC-1295 (No DAC) research guide.

Investigators often compare CJC-1295 (No DAC) to growth hormone secretagogues like Ipamorelin to evaluate synergistic GH release mechanisms in combined receptor binding models.

How CJC-1295 (No DAC) compares to CJC-1295 with DAC and related peptides

When designing GHRH research protocols, selecting the precise peptide variant is critical for kinetic accuracy. The primary distinction centers on the presence or absence of the Drug Affinity Complex (DAC), a maleimidopropionic acid linker.

Below is a comparison of common research GHRH analogs and secretagogues available in the PX1 Research catalog:

CJC-1295 (No DAC / Mod GRF 1-29): - Mechanism: Direct GHRH receptor agonist - Pharmacokinetics: Extended half-life relative to native GHRH (~30 minutes in animal models), maintaining physiological pulsatile GH release - Primary Research Focus: Acute GH pulse dynamics, tissue repair models, physiological secretagogue interaction studies

CJC-1295 with DAC: - Mechanism: GHRH receptor agonist with bioconjugation link - Pharmacokinetics: Significantly extended half-life (~6 to 8 days) via irreversible binding to circulating serum albumin - Primary Research Focus: Continuous elevated GH/IGF-1 baseline studies, long-term metabolic pathway evaluation. Explore our CJC-1295 with DAC page for specific parameter details.

Ipamorelin: - Mechanism: Selective Ghrelin/Growth Hormone Secretagogue Receptor (GHSR-1a) agonist - Pharmacokinetics: Rapid onset, short duration (~2 hours) - Primary Research Focus: Selective GH pulse generation without elevating cortisol, prolactin, or ACTH baseline levels.

Researchers investigating dual-pathway activation frequently examine co-administration dynamics using Mod GRF 1-29 alongside selective secretagogues within controlled preclinical designs.

How to vet a research peptide supplier: Red flags to avoid

Because research peptides operate under the RUO legal framework, vendor accountability varies widely across the online marketplace. Acquiring under-regulated, mislabeled, or contaminated peptides can compromise months of laboratory work, yielding invalid experimental data or toxicity in cellular assays.

When auditing potential peptide vendors for institutional compliance, look for these common red flags:

Red Flag 1: Human Consumption Marketing or Dosing Advice Any vendor providing dosage calculators for human body weight, injection guides, or anti-aging health claims is operating in direct violation of federal regulatory guidelines. These practices risk vendor shutdown and indicate a lack of compliance oversight.

Red Flag 2: Generic or Missing Certificate of Analysis (COA) Vendors that display static, non-batch-specific COAs—or rely on internal lab reports without independent verification—cannot guarantee purity or peptide content. Every lot must be verified independently.

Red Flag 3: Unverified Foreign Dropshipping Vendors that source and ship unverified materials directly from overseas facilities often subject buyers to customs seizures, degraded peptide integrity due to thermal instability during transit, and non-existent batch traceability.

Red Flag 4: Absence of Endotoxin Data Peptides intended for cell culture or in vivo animal research must be screened for bacterial endotoxins (lipopolysaccharides). High endotoxin levels trigger inflammatory cascades that corrupt experimental biological endpoints.

Evaluating these criteria ensures your laboratory secures reliable reagents while remaining fully aligned with legal standards.

Criteria for evaluating vendor legitimacy and regulatory compliance

To guarantee experimental reproducibility and strict compliance, institutional purchasing managers should evaluate suppliers against six standard criteria:

1. Purity Verification: Demand High-Performance Liquid Chromatography (HPLC) testing confirming a purity baseline of ≥98% for every single production lot.

2. Structural Identity Confirmation: Confirm identity via Mass Spectrometry (MS), verifying exact molecular weight against theoretical sequence mass.

3. Endotoxin Screening: Ensure Chromogenic LAL or recombinant Factor C assay verification proves endotoxin levels fall below standard research thresholds (<0.01 EU/mg).

4. Domestic Synthesis and Handling: Prioritize suppliers utilizing USA-based synthesis, cold-chain handling, and controlled climate storage to prevent peptide aggregation.

5. Complete Lot Traceability: Require batch numbers on individual vials that map directly to downloadable, third-party analytical reports.

6. Expedited Tracked Logistics: Ensure shipments dispatch rapidly from domestic distribution hubs using temperature-controlled packaging to minimize thermal exposure during transit.

PX1 Research satisfies every benchmark across these six operational criteria, establishing a transparent supply line for scientific laboratories.

Ordering CJC-1295 (No DAC) from PX1 Research

PX1 Research provides institutional buyers and laboratory researchers with pure, highly characterized CJC-1295 (No DAC) formulated specifically for demanding analytical applications. When you order from our catalog, you receive high-purity, lyophilized peptide material sealed in vacuum-capped glass vials designed to protect peptide stability during storage and handling.

We offer flexible research quantities to accommodate both bench-scale exploratory studies and larger high-throughput research projects. Every vial features a lot number that links directly to its independent analytical Certificate of Analysis, confirming HPLC purity, mass identity, and low endotoxin status.

Logistics are structured to meet strict laboratory timelines. Orders placed before 2 PM PST (5 PM EST) Monday through Friday dispatch same-day from our dual distribution facilities in California and Arizona. Shipments are fully tracked and delivered via expedited domestic transit networks.

Our customer support team is staffed by scientific specialists who can assist with documentation, batch verification, and commercial procurement workflows. To secure fully characterized reagents for your upcoming study, place an order directly on our CJC-1295 (No DAC) product page or browse our complete selection at /all-peptides.